We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-11.83%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$86.9M
AUM Growth
-$10.2M
Cap. Flow
+$1.9M
Cap. Flow %
2.19%
Top 10 Hldgs %
100%
Holding
11
New
7
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$1.06M
2
PSEC icon
Prospect Capital
PSEC
+$507K
3
SLRC icon
SLR Investment Corp
SLRC
+$202K
4
PFX icon
PhenixFIN
PFX
+$179K
5
ICMB icon
Investcorp Credit Management BDC
ICMB
+$136K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$379K

Sector Composition

Rank Sector Weight
1 Healthcare 93.46%
2 Financials 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.6B
$80M 92.06%
862,798
+87
+0% +$9K
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$4.4M 5.07%
2,246,469
– –
ALKS icon
3
Alkermes
ALKS
$8.66B
$1.22M 1.4%
+20,825
New +$1.06M
PSEC icon
4
Prospect Capital
PSEC
$1.17B
$454K 0.52%
+55,012
New +$507K
SLRC icon
5
SLR Investment Corp
SLRC
$725M
$198K 0.23%
+11,002
New +$202K
AGRX
6
DELISTED
Agile Therapeutics
AGRX
$182K 0.21%
15
+1
+7% +$12.7K
PFX icon
7
PhenixFIN
PFX
$80.3M
$152K 0.17%
+825
New +$179K
ICMB icon
8
Investcorp Credit Management BDC
ICMB
$12.4M
$124K 0.14%
+11,338
New +$136K
EVF
9
Eaton Vance Senior Income Trust
EVF
$90.3M
$96K 0.11%
+15,403
New +$98.1K
NSL
10
DELISTED
NUVEEN SENIOR INCM FD
NSL
$72K 0.08%
+11,002
New +$72.8K
COV
11
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-4,381
Closed -$379K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2014 Portfolio in Review

As of Q4 2014, Caxton Corporation held 11 positions worth $86.9M, down 11% from $97.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Caxton Corporation's Q4 2014 filing shows 7 new, 2 increased and 1 closed positions. Its largest new stake was Alkermes: 20,825 shares worth $1.22M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $379K.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier, followed by Financials.

  • Caxton Corporation's largest Q4 2014 buy was Alkermes: 20,825 shares worth $1.22M.
  • Caxton Corporation added most to Agile Therapeutics in Q4 2014, an estimated $12.7K increase.
  • Caxton Corporation fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $379K.
  • Caxton Corporation's ten largest holdings make up 100% of its $86.9M portfolio in Q4 2014.
  • Caxton Corporation opened 7 new positions and closed 1 in Q4 2014.
  • Caxton Corporation's portfolio value fell 11% quarter-over-quarter to $86.9M.

Based on Caxton Corporation's 13F filing for Q4 2014, filed 17 Feb 2015.